Functional dissection of the retron St-85 of Salmonella Typhimurium
鼠伤寒沙门氏菌逆转录子 St-85 的功能解剖
基本信息
- 批准号:9058463
- 负责人:
- 金额:$ 14.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-15 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Non-typhoidal Salmonellae are the leading cause of bacterial food borne gastroenteritis causing hundreds of millions cases of diarrhea and hundreds of thousands deaths world wide each year. The majority of cases originate from consumption of contaminated food products, but some are from direct contact with infected animals or people. Despite many years of study, the strategies used by this pathogen to survive within the gastrointestinal tract of natural hosts are poorly understood. In prior studies, I screened a pool of targeted gene deletion mutants of Salmonella Typhimurium in the bovine ligated ileal loop model, the model most closely mimicking human gastroenteritis. Among 31 novel candidate mutants under selection in this model, I identified a reverse transcriptase (STM3846, rrtT). I confirmed the fitness defect of a deletion mutant in STM3846 using competitive infection and complementation in both bovine and murine models of enterocolitis. In my preliminary data, I show that this enzyme is required to produce a multi-copy single-stranded DNA (msDNA) that is a unique RNA-DNA hybrid molecule of 85 nucleotides. The necessary elements for msDNA production are encoded in an operon termed a "retron" in many different bacterial species, and include msr (encoding the RNA primer), msd (template for reverse transcription) and a reverse transcriptase. Lack of a phenotype for mutants unable to make msDNA was a critical roadblock preventing identification of the natural function of this molecule despite more than 30 years of study. I have discovered that msDNA is essential for survival of Salmonella Typhimurium in the mammalian intestine, in anaerobic conditions, and at low temperature in vitro. These are the first phenotypes of msDNA mutants identified in any bacterial organism. With these phenotypes in hand, I am uniquely poised to identify functional regions of this molecule and to test hypotheses regarding its critical molecular tasks. To accomplish these goals, I will (1) elucidate the portion of msDNA from STm that has activity both in vitro and during infection, (2) investigate the function of msr by generating targeted mutations and determining the functionality of mutant msr both in vitro and during infection, and (3) determine the effect of expression of msDNA on global transcription and protein levels. This work will determine the key functional regions of msDNA and test hypotheses regarding its natural function. Because the msDNA molecule itself is totally novel and is clearly necessary during infection, this work will illuminate a novel paradigm in bacterial pathogenesis. This unique
RNA-DNA hybrid molecule represents a novel antimicrobial target for treatment of this important zoonotic pathogen either through inhibition of the molecule itself or the reverse transcriptase necessary for its production.
描述(由申请人提供):非类型沙门氏菌是细菌食品传播胃肠炎的主要原因,每年造成数亿例腹泻和数以千计的全球死亡。大多数病例源于消费受污染的食品,但有些来自与受感染的动物或人的直接接触。尽管有多年的研究,但这种病原体在天然宿主的胃肠道中生存的策略知之甚少。在先前的研究中,我筛选了牛腹膜沙门氏菌鼠伤寒的靶向基因缺失突变体池,该模型最紧密地模仿了人类胃炎的模型。在该模型中选择的31种新型候选突变体中,我确定了逆转录酶(STM3846,RRTT)。我确认了使用竞争性感染和小肠结肠炎模型中的竞争性感染和互补的STM3846中缺失突变体的适应性缺陷。在我的初步数据中,我表明这种酶是产生多拷贝的单链DNA(MSDNA),该单链DNA(MSDNA)是独特的RNA-DNA杂交分子的85个核苷酸。 MSDNA产生的必要元素被编码在许多不同细菌物种中称为“反龙”的操纵子中,包括MSR(编码RNA底漆),MSD(逆转录模板)和逆转录酶。缺乏无法制作MSDNA的突变体的表型是一个关键的障碍,尽管研究了30多年,但仍能鉴定出该分子的自然功能。我发现MSDNA对于在厌氧条件下和在低温体外生存对于哺乳动物肠中沙门氏菌伤寒的生存至关重要。这些是在任何细菌生物中鉴定出的MSDNA突变体的第一个表型。借助这些表型,我完全准备识别该分子的功能区域,并就其关键分子任务进行测试。为了实现这些目标,我将(1)阐明来自STM的MSDNA的一部分,在体外和感染过程中具有活性,(2)通过产生靶向突变并确定突变体MSR在体外和感染过程中的功能,以及(3)确定MSDNA表达对全球转录和蛋白质水平的影响。这项工作将确定MSDNA的关键功能区域和关于其自然功能的假设。因为MSDNA分子本身是完全新颖的,并且在感染过程中显然是必要的,所以这项工作将阐明细菌发病机理中新型的范式。这个独特
RNA-DNA杂交分子是通过抑制分子本身或其生产所需的逆转录酶来治疗这种重要人畜共患病原体的新型抗菌靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Johanna Rebecca El...的其他基金
Mechanistic evaluation of resistance to sulfite toxicity in Salmonella
沙门氏菌抗亚硫酸盐毒性的机制评价
- 批准号:1072456010724560
- 财政年份:2023
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
Functional dissection of the retron St-85 of Salmonella Typhimurium
鼠伤寒沙门氏菌逆转录子 St-85 的功能解剖
- 批准号:89203278920327
- 财政年份:2014
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
Functional dissection of the retron St-85 of Salmonella Typhimurium
鼠伤寒沙门氏菌逆转录子 St-85 的功能解剖
- 批准号:87658678765867
- 财政年份:2014
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
Functional dissection of the retron St-85 of Salmonella Typhimurium
鼠伤寒沙门氏菌逆转录子 St-85 的功能解剖
- 批准号:88493648849364
- 财政年份:2014
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
Functional dissection of the retron St-85 of Salmonella Typhimurium
鼠伤寒沙门氏菌逆转录子 St-85 的功能解剖
- 批准号:92663529266352
- 财政年份:2014
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
相似国自然基金
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
多肽纳米纤维水凝胶对灵长类动物急性脊髓损伤后脱髓鞘和再髓鞘化的保护作用及其机制
- 批准号:81972064
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
氨转运蛋白Rhcg在急性肝衰竭动物氨致脑水肿发生中的作用机制
- 批准号:
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
建立脑内急性基因编辑的孤独症非人灵长类动物模型
- 批准号:
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:专项基金项目
呼气末正压与动态/静态机械能比值的相关性研究:针对不同肺损伤模型的动物实验及初步临床验证
- 批准号:81871582
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
The Injectrode- An injectable, easily removable electrode as a trial lead for baroreceptor activation therapy to treat hypertension and heart failure
Injectrode——一种可注射、易于拆卸的电极,作为压力感受器激活疗法的试验引线,以治疗高血压和心力衰竭
- 批准号:1069760010697600
- 财政年份:2023
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Chronic Pancreatitis and Its Associated Pain
间充质干细胞治疗慢性胰腺炎及其相关疼痛的安全性和有效性
- 批准号:1072128410721284
- 财政年份:2023
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
Koli: A non-surgical solution for gallstone disease
Koli:胆结石疾病的非手术解决方案
- 批准号:1069894910698949
- 财政年份:2023
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
The First Non-Surgical Anti-Stomal Prolapse Medical Device to Treat and Prevent Stomal Prolapse
第一个治疗和预防造口脱垂的非手术防造口脱垂医疗器械
- 批准号:1048261610482616
- 财政年份:2022
- 资助金额:$ 14.52万$ 14.52万
- 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:1053248010532480
- 财政年份:2022
- 资助金额:$ 14.52万$ 14.52万
- 项目类别: